CLINICAL_TRIALS
trial_result
· 2014-04-21
Clinical Trial Update: Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer [Phase 3]
Summary
A Phase 3 sequential trial evaluating G17DT for advanced pancreatic cancer has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cancer Advances Inc. | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED